SPEAKER FACULTY

Anton Pekcec

Director - CardioRenalMetabolic Diseases Research

Boehringer Ingelheim

Cory Schwartz

Director, Research & Early Development

iBio

David Bearss Ph.D.

Co-Founder, CEO and President

Halia Therapeutics

David Tingley

Founder

Olio Labs

Dr. Raj Reddy

CEO

Canary Global

Gary Barnette

Chief Scientific Officer

Veru Inc.

Gordon Foulkes

Chief Executive Officer

Lipidio Pharmaceuticals

Ilan Zipkin

CEO

Supercede Therapeutics

Jeremiah Bearss

Vice President - Clinical Development

Biolexis Therapeutics

John Mayer

Chief Scientific Officer

Ambrosia Biosciences

Julia Dunn

AVP. Developement

Eli Lily

Laurent Audoly

Chief Executive Officer

Prive Bio

Martin Marro

Executive Director - Cell Pharmacology, Obesity & Complications

Eli Lily

Mitchell Steiner

Chairman, Chief Executive Officer & President

Veru Inc.

Patrice Lee

Head of R&D and Pharmacology

Ambrosia Biosciences

Robert Schott, MD

Chief Medical Officer

Rivus Pharmaceuticals, Inc.

Sara Gry Vienberg

Director, Scientific Strategy

Novo Nordisk

Tom Hardy

Chief Medical Officer

Adipo Therapeutics